160
Participants
Start Date
February 2, 2024
Primary Completion Date
May 20, 2024
Study Completion Date
June 1, 2024
Standard therapy group
Participants receive supplement prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.
AI-Guided group
Participants receive supplement prescriptions determined by GenAIS, is an AI system that considers genetic data, metabolic profiles, biochemical markers, and patient history.
Center of New Medical Technologies, Novosibirsk
Collaborators (1)
Triangel Scientific
INDUSTRY
Center of New Medical Technologies
OTHER
S.LAB (SOLOWAYS)
OTHER